JP4937532B2 - ワクチンストレス改善剤 - Google Patents
ワクチンストレス改善剤 Download PDFInfo
- Publication number
- JP4937532B2 JP4937532B2 JP2005170030A JP2005170030A JP4937532B2 JP 4937532 B2 JP4937532 B2 JP 4937532B2 JP 2005170030 A JP2005170030 A JP 2005170030A JP 2005170030 A JP2005170030 A JP 2005170030A JP 4937532 B2 JP4937532 B2 JP 4937532B2
- Authority
- JP
- Japan
- Prior art keywords
- vaccination
- vaccine
- stress
- ward
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960005486 vaccine Drugs 0.000 title claims description 85
- 238000002255 vaccination Methods 0.000 claims description 91
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 70
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 claims description 48
- 244000144977 poultry Species 0.000 claims description 38
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 34
- 239000005770 Eugenol Substances 0.000 claims description 34
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 34
- 229960002217 eugenol Drugs 0.000 claims description 34
- 244000144972 livestock Species 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 240000008474 Pimenta dioica Species 0.000 claims description 24
- 235000006990 Pimenta dioica Nutrition 0.000 claims description 24
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 claims description 24
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 claims description 24
- 244000223014 Syzygium aromaticum Species 0.000 claims description 21
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 21
- 229930003270 Vitamin B Natural products 0.000 claims description 17
- 239000004480 active ingredient Substances 0.000 claims description 17
- 235000019156 vitamin B Nutrition 0.000 claims description 17
- 239000011720 vitamin B Substances 0.000 claims description 17
- 208000016261 weight loss Diseases 0.000 claims description 14
- 230000004580 weight loss Effects 0.000 claims description 14
- 230000004596 appetite loss Effects 0.000 claims description 11
- 208000019017 loss of appetite Diseases 0.000 claims description 10
- 235000021266 loss of appetite Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 208000022531 anorexia Diseases 0.000 claims description 4
- 206010061428 decreased appetite Diseases 0.000 claims description 4
- 241000287828 Gallus gallus Species 0.000 description 50
- 235000013330 chicken meat Nutrition 0.000 description 49
- 230000035882 stress Effects 0.000 description 46
- 235000013594 poultry meat Nutrition 0.000 description 34
- 239000003921 oil Substances 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 29
- 208000015181 infectious disease Diseases 0.000 description 27
- 238000012360 testing method Methods 0.000 description 26
- 239000000341 volatile oil Substances 0.000 description 23
- 208000010359 Newcastle Disease Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 230000002458 infectious effect Effects 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 230000004584 weight gain Effects 0.000 description 10
- 235000019786 weight gain Nutrition 0.000 description 10
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 9
- 230000037396 body weight Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003746 feather Anatomy 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 6
- 206010006451 bronchitis Diseases 0.000 description 6
- 230000017448 oviposition Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000016784 immunoglobulin production Effects 0.000 description 5
- 229940031551 inactivated vaccine Drugs 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000283073 Equus caballus Species 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- 235000019192 riboflavin Nutrition 0.000 description 4
- 239000002151 riboflavin Substances 0.000 description 4
- -1 sesquiterpene hydrocarbons Chemical class 0.000 description 4
- 241000272517 Anseriformes Species 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 229940117948 caryophyllene Drugs 0.000 description 3
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 206010039083 rhinitis Diseases 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 2
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 2
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 201000005807 Japanese encephalitis Diseases 0.000 description 2
- 241000710842 Japanese encephalitis virus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000219926 Myrtaceae Species 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000001353 eugenia caryophyllata l. Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000020604 functional milk Nutrition 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 229960001103 hydroxocobalamin Drugs 0.000 description 2
- 235000004867 hydroxocobalamin Nutrition 0.000 description 2
- 239000011704 hydroxocobalamin Substances 0.000 description 2
- 239000001622 pimenta officinalis fruit oil Substances 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000906543 Actaea racemosa Species 0.000 description 1
- 101710196692 Actin A Proteins 0.000 description 1
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000010370 Adenoviridae Infections Diseases 0.000 description 1
- 206010060931 Adenovirus infection Diseases 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000711443 Bovine coronavirus Species 0.000 description 1
- 208000027312 Bursal disease Diseases 0.000 description 1
- FAPWYRCQGJNNSJ-UHFFFAOYSA-L Calcium DL-pantothenate Chemical compound [Ca+2].OCC(C)(C)C(O)C(=O)NCCC([O-])=O.OCC(C)(C)C(O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UHFFFAOYSA-L 0.000 description 1
- 241000754798 Calophyllum brasiliense Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241001299893 Chuzan virus Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 208000001528 Coronaviridae Infections Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241000702680 Equine rotavirus Species 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 208000000666 Fowlpox Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000606831 Histophilus somni Species 0.000 description 1
- 241000702377 Inovirus Species 0.000 description 1
- 241000653542 Kasba virus Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 208000006758 Marek Disease Diseases 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000019202 Orthocoronavirinae infectious disease Diseases 0.000 description 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000008104 Reoviridae Infections Diseases 0.000 description 1
- 206010051497 Rhinotracheitis Diseases 0.000 description 1
- 206010067470 Rotavirus infection Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- 208000024949 Swine Erysipelas Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010051511 Viral diarrhoea Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- BTNNPSLJPBRMLZ-LGMDPLHJSA-N benfotiamine Chemical compound C=1C=CC=CC=1C(=O)SC(/CCOP(O)(O)=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N BTNNPSLJPBRMLZ-LGMDPLHJSA-N 0.000 description 1
- 229960002873 benfotiamine Drugs 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229910000361 cobalt sulfate Inorganic materials 0.000 description 1
- 229940044175 cobalt sulfate Drugs 0.000 description 1
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000002491 encephalomyelitis Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- JTLXCMOFVBXEKD-FOWTUZBSSA-N fursultiamine Chemical compound C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N JTLXCMOFVBXEKD-FOWTUZBSSA-N 0.000 description 1
- 229950006836 fursultiamine Drugs 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 201000009837 laryngotracheitis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940068459 sodium pantothenate Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019191 thiamine mononitrate Nutrition 0.000 description 1
- 239000011748 thiamine mononitrate Substances 0.000 description 1
- 229960004860 thiamine mononitrate Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
オイルワクチン未接種のジュリア種の鶏80羽(10羽×4種類×2反復)(日令63〜91日令)を4区に分けて供試した。第1区と第2区を比較区とし、第3区と第4区を試験区とした。ワクチン接種は、7種混合オイルワクチン「商品名 オイルバックス7」(財団法人化学及血清療法研究所製)(ワクチン接種日令:70日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+クローブなど)を給餌し、残りの期間は表1に示す基礎飼料を給餌した。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定した。結果を表2に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+クローブ 0.05質量%
第4区:ワクチン接種あり 基礎飼料+オールスパイス0.10質量%
ジュリア種の鶏80羽(10羽×4種類×2反復)(日令107〜135日令)を4区に分けて供試した。第1区と第2区を比較区とし、第3区と第4区を試験区とした。ワクチン接種は、7種混合オイルワクチン「商品名 オイルバックス7」(財団法人化学及血清療法研究所製)(ワクチン接種日令:114日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+クローブなど)を給餌し、残りの期間は、表1に示す基礎飼料を給餌した。供試した鶏は、70日令に既に1回7種混合オイルワクチン(化血研)接種済みの鶏を用いた。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定し、結果を表3に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+クローブ 0.05質量%
第4区:ワクチン接種あり 基礎飼料+オールスパイス0.10質量%
オイルワクチン未接種のジュリア種の鶏60羽(10羽×3種類×2反復)(日令62〜90日令)を3区に分けて供試した。第1区と第2区を比較区とし、第3区を試験区とした。ワクチン接種は、7種混合オイルワクチン「商品名 オイルバックス7」(財団法人化学及血清療法研究所製)(ワクチン接種日令:69日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+オールスパイス)を給餌し、残りの期間は表1に示す基礎飼料を給餌した。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定し、結果を表4に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+オールスパイス0.05質量%
オイルワクチン未接種のジュリア種の鶏100羽(10羽×5種類×2反復)(日令62〜90日令)を5区に分けて供試した。第1区と第2区を比較区とし、第3〜5区を試験区とした。ワクチン接種は、7種混合オイルワクチン「商品名 オイルバックス7」(財団法人化学及血清療法研究所製)(ワクチン接種日令:69日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+オイゲノールなど)を給餌し、残りの期間は表1に示す基礎飼料を給餌した。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定し、結果を表5に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+精油(オイゲノール100%)0.005質量%
第4区:ワクチン接種あり 基礎飼料+精油(オイゲノール90%:β−カリオフィレン10%)0.005質量%
第5区:ワクチン接種あり 基礎飼料+精油(オイゲノール70%:β−カリオフィレン30%)0.005質量%
ジュリア種の鶏120羽(10羽×6種類×2反復)(日令97〜125日令)を6区に分けて供試した。第1〜3区を比較区とし、第4〜6区を試験区とした。ワクチン接種は、7種混合オイルワクチン「商品名 オイルバックス7」(財団法人化学及血清療法研究所製)(ワクチン接種日令:104日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+オールスパイスなど)を給餌し、残りの期間は表1に示す基礎飼料を給餌した。ビタミンB群としては、ビタミンB2(10.0質量%)、ビタミンB12(0.0225質量%)、パントテン酸(15.0質量%)、ニコチン酸(55.0質量%)、炭酸カルシウム(19.9775質量%)の混合物を用いた。供試した鶏は、69日令に既に1回7種混合オイルワクチン(化血研)接種済みの鶏を用いた。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定し、結果を表6に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+ビタミンB群0.02質量%
第4区:ワクチン接種あり 基礎飼料+ビタミンB群0.02質量%+オールスパイス0.05質量%
第5区:ワクチン接種あり 基礎飼料+ビタミンB群0.02質量%+精油(オイゲノール90質量%:β−カリオフィレン10質量%)0.005質量%
第6区:ワクチン接種あり 基礎飼料+ビタミンB群+精油(オイゲノール70質量%:β−カリオフィレン30質量%)0.005質量%
オイルワクチン未接種のジュリア種の鶏60羽(10羽×3種類×2反復)(日令63〜91日令)を3区に分けて供試した。第1区と第2区を比較区とし、第3区を試験区とした。ワクチン接種は、3種混合オイルワクチン「商品名 NBMg混合不活化ワクチン(New Brons MG)」(Fort Dodge Animal Health社製、ゲン・コーポレーション販売)(ワクチン接種日令:65日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+オイゲノールなど)を給餌し、残りの期間は表1に示す基礎飼料を給餌した。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定し、結果を表7に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+ビタミンB群0・02質量%+精油(オイゲノール90%:β−カリオフィレン10%)0.005質量%
オイルワクチン未接種のジュリア種の鶏60羽(10羽×3種類×2反復)(日令58〜86日令)を3区に分けて供試した。第1区と第2区を比較区とし、第3区を試験区とした。ワクチン接種は、6種混合オイルワクチン「商品名 “京都微研”ニワトリ6種混合オイルワクチン」(微生物化学研究所社製)(ワクチン接種日令:65日令)を鶏脚部筋肉中に0.5ml/羽を接種することにより行った。比較区には、表1に示す基礎飼料(大雛用飼料)を28日間給餌し、試験区には、ワクチン接種日±7日間(14日間)は、試験飼料(基礎飼料+オイゲノールなど)を給餌し、残りの期間は表1に示す基礎飼料を給餌した。体重及び食下量(4週間累計)とワクチン抗体価(ワクチン接種後21日目)を測定し、結果を表8に示す。
(区分)
第1区:ワクチン接種なし 基礎飼料
第2区:ワクチン接種あり 基礎飼料
第3区:ワクチン接種あり 基礎飼料+ビタミンB群0.02質量%+精油(オイゲノール90質量%+β−カリオフィレン10質量%)0.005質量%
Claims (4)
- オールスパイス及び/又はクローブを有効成分として含有する、家禽・家畜類のワクチン接種によるストレス改善剤であって、食欲不振、及び体重の減少に対し有効に作用すると共にワクチン抗体価を高めるための前記ストレス改善剤。
- オイゲノールを有効成分として含有する、又は、オイゲノール及びβ−カリオフィレンを有効成分として含有する、家禽・家畜類のワクチン接種によるストレス改善剤であって、食欲不振、及び体重の減少に対し有効に作用すると共にワクチン抗体価を高めるための前記ストレス改善剤。
- さらに、ビタミンB群を含有することを特徴とする請求項1又は2記載のストレス改善剤。
- 請求項1〜3のいずれか記載の家禽・家畜類のワクチン接種によるストレス改善剤を家禽・家畜類に投与することを特徴とする家禽・家畜類のワクチン接種による、食欲不振、及び体重の減少に対し有効に作用すると共にワクチン抗体価を高めるためのストレス改善方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005170030A JP4937532B2 (ja) | 2005-06-09 | 2005-06-09 | ワクチンストレス改善剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005170030A JP4937532B2 (ja) | 2005-06-09 | 2005-06-09 | ワクチンストレス改善剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006342111A JP2006342111A (ja) | 2006-12-21 |
JP4937532B2 true JP4937532B2 (ja) | 2012-05-23 |
Family
ID=37639335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005170030A Active JP4937532B2 (ja) | 2005-06-09 | 2005-06-09 | ワクチンストレス改善剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4937532B2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2535119T3 (es) * | 2007-09-11 | 2015-05-05 | Dsm Ip Assets B.V. | Uso de sesquiterpenos como aditivos de piensos en alimentación animal |
CN111669975A (zh) * | 2017-12-18 | 2020-09-15 | 因特热内(私人)有限公司 | 水添加剂和组合物 |
CN111011270B (zh) * | 2019-12-05 | 2021-12-07 | 天津农学院 | 一种缓解鱼类运输应激的方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1320180B1 (it) * | 2000-12-29 | 2003-11-26 | Hunza Di Marazzita Maria Carme | Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e |
JP2004002237A (ja) * | 2002-05-31 | 2004-01-08 | Noriko Yagi | 老化防止ハーブ |
-
2005
- 2005-06-09 JP JP2005170030A patent/JP4937532B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2006342111A (ja) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Landy et al. | Performance, carcass characteristics, and immunity in broiler chickens fed dietary neem (Azadirachta indica) as alternative for an antibiotic growth promoter | |
Özek et al. | Effects of dietary herbal essential oil mixture and organic acid preparation on laying traits, gastrointestinal tract characteristics, blood parameters and immune response of laying hens in a hot summer season | |
Al-Mufarrej | Immune-responsiveness and performance of broiler chickens fed black cumin (Nigella sativa L.) powder | |
Gao et al. | Effects of yeast culture in broiler diets on performance and immunomodulatory functions | |
Khaligh et al. | Evaluation of different medicinal plants blends in diets for broiler chickens | |
Fallah et al. | Effect of dietary inclusion of turmeric and thyme powders on performance, blood parameters and immune system of broiler chickens. | |
Attia et al. | Utilisation of thyme powder (Thyme vulgaris L.) as a growth promoter alternative to antibiotics for broiler chickens raised in a hot climate. | |
El Sayed et al. | The use of propolis as vaccine's adjuvant | |
Amakye-Anim et al. | Ascorbic acid supplementation improved antibody response to infectious bursal disease vaccination in chickens | |
Thayalini et al. | Effects of Cymbopogon citratus leaf and Zingiber officinale rhizome supplementation on growth performance, ileal morphology and lactic acid concentration in broilers | |
Abbas et al. | Effects of formic acid administration in the drinking water on production performance, egg quality and immune system in layers during hot season | |
JP4937532B2 (ja) | ワクチンストレス改善剤 | |
Ghasemi et al. | Comparison of broiler performance, blood biochemistry, hematology and immune response when feed diets were supplemented with ginger essential oils or mannan-oligosaccharide. | |
Farhadi et al. | Influence of using sage powder (Salvia officinalis) on performance, blood cells, immunity titers, biochemical parameters and small intestine morphology in broiler chickens. | |
Lin et al. | Effect of dietary vitamin E on growth performance and immune response of breeder chickens | |
KR20090088121A (ko) | 항원-항체 복합체를 이용한 불활화 백신의 제조방법 및이의 수의학적 조성물로서의 용도 | |
Shihab | Effect of defferent levels of turmeric supplementation with diet on humoral immune response to newcastle and infectious bursal disease virus and histopathological changes of some internal organ of broiler chickens | |
JP2008019251A (ja) | ストレスの改善剤 | |
Dehghani et al. | Effects of dietary organic acid supplementation on immune responses and some blood parameters of broilers fed diets with different protein levels | |
KR20220033568A (ko) | 뉴캐슬 백신 면역 증진용 미생물 제제 | |
Abbass et al. | Effect of peppermint, fenugreek and their mixture on production traits of heat stressed broiler chickens | |
Molina-Barrios et al. | Effect of dietary stevia-based sweetener on body weight and humoral immune response of broiler chickens | |
Priya et al. | The effect of Tinospora cordifolia (Seenthil chooranam) in broiler chicken | |
Al-Beitawi et al. | Effect of adding crushed Pimpinella anisum, Nigella sativa seeds and Thymus vulgaris mixture to antibiotics-free rations of vaccinated and non-vaccinated male broilers on growth performance, antibody titer and haematological profile | |
Sumithra et al. | Ameliorative effect of Panchagavya on Newcastle disease in layer chicken. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080428 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110719 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110920 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111026 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111214 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120131 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120222 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150302 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4937532 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |